UNSPSC 51262700: Adrenergic blocking agent imidazolines

This classification denotes adrenergic blocking agents made from compounds based on reduced imidazoles containing a single double bond.

UNSPSC 51262700 Adrenergic blocking agent imidazolines is a Class code that in practice does not align with the state and local procurement activity tagged under it. The recent opportunity posted under this code—Seminole County, Florida's June 2026 IFB for naloxone and drug deactivation systems—represents emergency response and public health supply procurement, not pharmaceutical blocking agents. The mismatch suggests either a cataloging error in the jurisdiction's procurement tagging or that the code is being misapplied to a broader class of pharmaceutical and medical supplies than its nominal scope implies. State and local health departments and county public health agencies appear to be the primary issuing bodies using this code, though the single recent record offers limited insight into whether this represents a pattern or an isolated instance.

Seminole County, Florida is the only jurisdiction with a recent tracked opportunity under this code. The IFB 60459723LAS, posted June 30, 2026, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023 (a date inconsistency in the source record itself). The contract carried a two-year initial term with a one-year renewal option and included FEMA funding compliance requirements. Beyond this single record, geographic spread and issuing-body concentration cannot be characterized reliably. Business development professionals evaluating this code should verify whether procurement activity is genuinely sparse or whether tagging inconsistencies are masking opportunities under related pharmaceutical or emergency supplies codes.